4.6 Review

Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular Models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

A Basomedial Amygdala to Intercalated Cells Microcircuit Expressing PACAP and Its Receptor PAC1 Regulates Contextual Fear

Abha K. Rajbhandari et al.

Summary: Trauma can lead to dysfunctional fear regulation and development of disorders like PTSD. Research in mice showed that the PACAPergic pathway can modulate fear and fear extinction. Selective deletion of PAC1 receptors in mICCs in females may affect fear acquisition, generalization, and extinction, with modulation dependent on behavioral state.

JOURNAL OF NEUROSCIENCE (2021)

Review Neurosciences

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Gregory C. Johnson et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Review Geriatrics & Gerontology

PACAP deficiency as a model of aging

D. Reglodi et al.

GEROSCIENCE (2018)

Article Genetics & Heredity

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

Christian R. Marshall et al.

NATURE GENETICS (2017)

Article Psychology, Developmental

Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2

Beth Wilmot et al.

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2016)

Review Neurosciences

Dendritic spine alterations in schizophrenia

Caitlin E. Moyer et al.

NEUROSCIENCE LETTERS (2015)

Article Multidisciplinary Sciences

The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans

Kristin G. Ardlie et al.

SCIENCE (2015)

Article Behavioral Sciences

Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice

Tomris Mustafa et al.

STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2015)

Article Biochemistry & Molecular Biology

Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals

Alexis Battle et al.

GENOME RESEARCH (2014)

Article Multidisciplinary Sciences

A polygenic burden of rare disruptive mutations in schizophrenia

Shaun M. Purcell et al.

NATURE (2014)

Article Multidisciplinary Sciences

Biological insights from 108 schizophrenia-associated genetic loci

Stephan Ripke et al.

NATURE (2014)

Review Pharmacology & Pharmacy

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair

J. A. Waschek

BRITISH JOURNAL OF PHARMACOLOGY (2013)

Article Multidisciplinary Sciences

Definition and refinement of the 7q36.3 duplication region associated with schizophrenia

Branko Aleksic et al.

SCIENTIFIC REPORTS (2013)

Review Genetics & Heredity

DISEASE MECHANISMS Genetic architectures of psychiatric disorders: the emerging picture and its implications

Patrick F. Sullivan et al.

NATURE REVIEWS GENETICS (2012)

Article Behavioral Sciences

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice

Satoko Hattori et al.

Frontiers in Behavioral Neuroscience (2012)

Review Pharmacology & Pharmacy

VIP-induced Neuroprotection of the Developing Brain

Sandrine Passemard et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Review Pharmacology & Pharmacy

PACAP is Implicated in the Stress Axes

Hitoshi Hashimoto et al.

CURRENT PHARMACEUTICAL DESIGN (2011)

Article Multidisciplinary Sciences

Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor

Kerry J. Ressler et al.

NATURE (2011)

Article Neurosciences

Neurobiological Basis of Failure to Recall Extinction Memory in Posttraumatic Stress Disorder

Mohammed R. Milad et al.

BIOLOGICAL PSYCHIATRY (2009)

Article Pharmacology & Pharmacy

Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

D. Vaudry et al.

PHARMACOLOGICAL REVIEWS (2009)

Article Biochemistry & Molecular Biology

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia

R. Hashimoto et al.

MOLECULAR PSYCHIATRY (2007)

Review Pharmacology & Pharmacy

Vasoactive intestinal peptide in neurodevelopmental disorders: Therapeutic potential

Joanna M. Hill

CURRENT PHARMACEUTICAL DESIGN (2007)

Article Endocrinology & Metabolism

Growth factor-dependent actions of PACAP on oligodendrocyte progenitor proliferation

Vincent Lelievre et al.

REGULATORY PEPTIDES (2006)

Article Pharmacology & Pharmacy

VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice

CM Rangon et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)

Article Multidisciplinary Sciences

Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)

H Hashimoto et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice

SB Shen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)